Fifth Third Bancorp/Abraxis Bioscience SC 13G
 

     
 
OMB APPROVAL
 
 
OMB Number: 3235-0145
 
 
Expires: February 28, 2009
 
 
Estimated average burden hours per response...10.4
 
 
 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. )*

Abraxis Bioscience.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
00383E106
(CUSIP Number)
December 31, 2006
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

þ Rule 13d-1(b)

o Rule 13d-1(c)

o Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
 


 

                     
CUSIP No.
 
00383E106 
Schedule 13 G Page  
  of   

 

           
1   NAMES OF REPORTING PERSONS:
FIFTH THIRD BANCORP
   
  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): 
    31-0854434
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):

  (a)   o
  (b)   o
     
3   SEC USE ONLY:
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION:
   
  OHIO
       
  5   SOLE VOTING POWER:
     
NUMBER OF   8,684,488 shares
       
SHARES 6   SHARED VOTING POWER:
BENEFICIALLY    
OWNED BY   0 shares
       
EACH 7   SOLE DISPOSITIVE POWER:
REPORTING    
PERSON   33,000 shares
       
WITH: 8   SHARED DISPOSITIVE POWER:
     
    450 shares
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
   
  8,684,488
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
   
  5.24%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
   
  HC

This report relates to beneficial holdings by Fifth Third Bancorp, through several of its subsidiaries, of outstanding shares of the Common Stock of the Issuer. The following tabulations set forth the shares with respect of which voting rights are held or shared and those shares to which there is dispositive power. The following are held in fiduciary accounts in Fifth Third Bancorp’s subsidiaries and are deemed beneficially owned:

 


 

Securities and Exchange Commission
Schedule 13G
Page 3 of 7 pages
     
Item 1(a).
  Name of Issuer:
 
   
 
  Abraxis Bioscience
 
   
Item 1(b).
  Address of Issuer’s Principal Executive Offices:
 
   
 
  11755 wilshire Blvd., 20th Floor
Los Angeles,CA 90025
 
   
Item 2(a).
  Name of Person Filing:
 
   
 
  Fifth Third Bancorp
 
   
Item 2(b).
  Address of Principal Business Office or, if None, Residence:
 
   
 
  Fifth Third Center, Cincinnati, Ohio 45263
 
   
Item 2(c).
  Citizenship:
 
   
 
  Ohio
 
   
Item 2(d).
  Title of Class of Securities:
 
   
 
  Common Stock
 
   
Item 2(e).
  CUSIP Number:
 
   
 
  00383E106

 


 

Securities and Exchange Commission
Schedule 13G
Page 4 of 7 pages
         
Item 3.   If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
 
  (a)   o Broker or dealer registered under Section 15 of the Act;
 
 
  (b)   o Bank as defined in Section 3(a)(6) of the Act;
 
 
  (c)   o Insurance company as defined in Section 3(a)(19) of the Act;
 
 
  (d)   o Investment company registered under Section 8 of the Investment Company Act;
 
 
  (e)   o Investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
 
 
  (f)   o Employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
 
 
  (g)   þ Parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
 
 
  (h)   o Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;
 
 
  (i)  
o Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;
 
 
  (j)   o Group, in accordance with Rule 13d-1(b)(1)(ii)(J).

 


 

Securities and Exchange Commission
Schedule 13G
Page 5 of 7 pages
                     
Item 4.
  Ownership                
 
                   
    This report relates to beneficial holdings by Fifth Third Bancorp, through several of its subsidiaries, of outstanding shares of the Common Stock of the Issuer. The following tabulations set forth the shares with respect of which voting rights are held or shared and those shares to which there is dispositive power. The following are held in fiduciary accounts in Fifth Third Bancorp’s subsidiaries and are deemed beneficially owned:
 
                   
    (a)   Amount Beneficially Owned:   8,684,488 shares
 
                   
    (b)   Percent of Class:     5.24 %
 
                   
    (c)   Number of shares as to which such person has:        
 
                   
 
      (i)   Sole power to vote or to direct the vote   8,684,488 shares
 
      (ii)   Shared power to vote or to direct the vote   0 shares
 
      (iii)   Sole power to dispose or to direct the disposition of   33,000 shares
 
      (iv)   Shared power to dispose or to direct the disposition of   450 shares
 
                   
Item 5.   Ownership of Five Percent or Less of a Class        
 
                   
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o.
 
                   
Item 6.   Ownership of More than Five Percent on Behalf of Another Person        
 
                   
 
  n/a                

 


 

Securities and Exchange Commission
Schedule 13G
Page 6 of 7 pages
             
Item 7.   Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company
 
           
    Fifth Third Bancorp, as parent holding company of the subsidiaries listed below, has filed this schedule. The subsidiaries are filing in accordance with Rule 13d-1(b)(1)(ii)(G).
 
           
    Subsidiary   Item 3 Classification
     
 
           
 
  Fifth Third Bank       Bank
 
  Fifth Third Bank (Tennessee)       Bank
 
  Fifth Third Bank (Michigan)       Bank
 
  Fifth Third Asset Management, Inc.       Investment Adviser
 
           
Item 8.
  Identification and Classification of Members of the Group        
 
           
 
  Not Applicable        
 
           
Item 9.
  Notice of Dissolution of Group        
 
           
 
  Not Applicable        
 
Item 10.
  Certifications By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 


 

Securities and Exchange Commission
Schedule 13G
Page 7 of 7 pages
SIGNATURE
             
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete andcorrect
 
           
 
      Fifth Third Bancorp    
 
           
 
      /S/ Charles Drucker   February 14, 2007
             
 
      Executive Vice President   Today’s Date